Dekkers Leaves Thermo Fisher for Bayer

Sep 15, 2009

NEW YORK (GenomeWeb News) – Marijn Dekkers has resigned his position as president, CEO, and member of the board of directors at Thermo Fisher Scientific to take over as CEO of German drug, chemicals, and life science giant Bayer.

Thermo Fisher has appointed current COO Marc Casper to become president, CEO, and board member effective Oct. 15, 2009.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

NIH's Collins on Harassment

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

With Eight Arms and Giant Eyes

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Missing From Trials

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

This Week in Cell

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.

Main menu